Grant: Postgraduate Scholarships - Doctoral
University of Cambridge
$40,000.00
Developing a Novel Class of DNA-based Antibiotics: Degrading Riboswitches to Exact Transcriptional Control Over Antibiotic-Resistant Bacteria
EF 2024-25
Résumé
Antibiotic Development, Nucleic Acid Technologies, Biologic Therapeutics, Bionanotechnology, Biological Chemistry, Post-transcriptional Gene Regulation, Engineered DNA Enzymes, Drug Resistant Bacteria
Programme
Postgraduate Scholarships - Doctoral
Bénéficiaire
Emplacement
UNITED KINGDOM
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
577849-2023
Name nom
Corbett, Alexander AL
Department département
Chemical Engineering
Organization id
333
Institution établissement
University of Cambridge
Country en
UNITED KINGDOM
Country fr
ROYAUME-UNI
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
40000
Program id
PGSD
Program name en
Postgraduate Scholarships - Doctoral
Program name fr
Bourses d'études supérieures - doctorat
Group en
RESEARCH TRAINING AND TALENT DEVELOPMENT
Group fr
FORMATION EN RECHERCHE ET PERFECTIONNEMENT DES COM
Committee code
194
Committee name en
S&F Selection Committee for Engineering B
Committee name fr
Comité de sélection des bourses en génie B
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Developing a Novel Class of DNA-based Antibiotics: Degrading Riboswitches to Exact Transcriptional Control Over Antibiotic-Resistant Bacteria
Application summary
Antibiotic Development, Nucleic Acid Technologies, Biologic Therapeutics, Bionanotechnology, Biological Chemistry, Post-transcriptional Gene Regulation, Engineered DNA Enzymes, Drug Resistant Bacteria
